Redefining Success: Individualizing HBV Care

As emerging therapies expand the potential for functional cure in chronic hepatitis B, this endpoint may be appropriate for some patients, but not all. This symposium will explore individualized treatment goals, including durable viral suppression, partial cure, and functional cure, and how patient characteristics and preferences guide treatment decisions.

• CE: 1.5 CME Hours
• Supported by: Aligos Therapeutics
• Organized by: Clinical Care Options, LLC dba Decera Clinical Education
• For more information and to register, visit: http://deceraclinical.com/education/2026HBVCareDenver